Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

NETWORK 2OTHER 1

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Leukemia 8Lymphoma 7Breast Neoplasms 6Lymphoma, Follicular 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Kidney Neoplasms 3Wilms Tumor 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Leukemia, Megakaryoblastic, Acute 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pleuropulmonary blastoma 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Carboplatin 7Paclitaxel 6Radiotherapy 5Cisplatin 4Bevacizumab 4Cetuximab 2Amplified Fragment Length Polymorphism Analysis 2pegfilgrastim 1advexin 1Temozolomide 1Surgical Procedures, Operative 1Radiotherapy, Conformal 1Radiosurgery 1Polymerase Chain Reaction 1Pneumonectomy 1Pharmacogenomic Testing 1Pemetrexed 1Panitumumab 1Neoadjuvant Therapy 1Injections 1Immunohistochemistry 1Glutamic Acid 1Gene Expression Profiling 1Gemcitabine 1Filgrastim 1Etoposide 1Erlotinib Hydrochloride 1Early Intervention, Educational 1Docetaxel 1Chromosome Mapping 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma, Bronchiolo-Alveolar × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT00897533 2017-05-19

Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer

Eastern Cooperative Oncology Group

Completed
137 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00900172 2017-05-19

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Eastern Cooperative Oncology Group

Completed
180 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡